KROS · NASDAQ · Biotechnology

Keros Therapeutics (KROS)

Develops protein therapeutics for neuromuscular disease and blood-cell disorders.

$11.71
vs last close−0.02 (−0.20%)
  1. KROS: Is the Discount Book Value a Value Trap?

    Zacks Investment Research